POWW.NASDAQAmmo, INC

8-K: AMMO, Inc. Faces Nasdaq Delisting Threat Due to Delayed Quarterly Report

Sentiment:

8-K Filing


AMMO, Inc. received a deficiency notice from Nasdaq for failing to file its quarterly report on time, putting its listing status at risk.

Delay expectedThe company's quarterly report is delayed due to an ongoing independent investigation.
Worse than expectedThe company received a deficiency notice from Nasdaq for failing to file its quarterly report on time, indicating a significant issue with their financial reporting process.

Summary

  • AMMO, Inc. received a notification from Nasdaq on November 20, 2024, stating they are not in compliance with listing rules due to the late filing of their quarterly report for the period ending September 30, 2024.
  • The delay is a result of an ongoing independent investigation being conducted by a law firm retained by a special committee of the board.
  • AMMO has until January 21, 2025, to submit a plan to regain compliance.
  • If Nasdaq accepts the plan, they may grant an extension of up to 180 days, until May 19, 2025, for AMMO to file the report.
  • There is no guarantee that AMMO will regain compliance or maintain its listing on Nasdaq.
  • Failure to regain compliance could lead to delisting, which the company could appeal.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the delisting risk and the ongoing investigation, which suggests potential underlying issues. The company's future is uncertain.

Positives

  • The company intends to submit a plan to regain compliance with Nasdaq listing rules.
  • Nasdaq may grant an extension of up to 180 days to regain compliance.
  • The company is working diligently to complete the quarterly report as soon as practicable.

Negatives

  • AMMO, Inc. is not in compliance with Nasdaq listing rules due to a late filing.
  • The delay is due to an ongoing independent investigation, which suggests potential underlying issues.
  • There is a risk of delisting if the company fails to regain compliance within the given timeframe.
  • The company cannot provide specific timing regarding the filing of the Form 10-Q.

Risks

  • The ongoing independent investigation could uncover further issues.
  • Nasdaq may not accept the company's plan to regain compliance.
  • The company may not be able to meet the extended deadline for filing the quarterly report.
  • There is a risk of delisting from Nasdaq if compliance is not achieved.
  • The company's share price could be negatively impacted by the delisting risk.

Future Outlook

The company intends to submit a plan to regain compliance with Nasdaq listing rules and is working to file the delayed quarterly report as soon as practicable, but there is no guarantee of success and delisting remains a risk.

Management Comments

  • The company intends to timely submit the Plan, if necessary.
  • The company continues to work diligently to complete the Form 10-Q and intends to file the Form 10-Q as soon as practicable to regain compliance with the Listing Rule within the Compliance Period.

Industry Context

This announcement highlights the importance of timely financial reporting for publicly listed companies and the potential consequences of non-compliance. It also underscores the scrutiny that companies face when undergoing internal investigations.

Comparison to Industry Standards

  • Failure to file quarterly reports on time is a serious breach of Nasdaq listing rules, and many companies have been delisted for similar reasons.
  • Companies like iBio, Inc. and China Jo-Jo Drugstores, Inc. have faced similar delisting threats due to late filings, highlighting the importance of maintaining compliance.
  • The 180-day extension period is a standard procedure for companies facing delisting, but it is not a guarantee of continued listing.

Stakeholder Impact

  • Shareholders face the risk of delisting and potential loss of investment value.
  • Employees may experience uncertainty about the company's future.
  • Customers and suppliers may be concerned about the company's stability.

Next Steps

  • AMMO, Inc. needs to submit a plan to Nasdaq by January 21, 2025, to regain compliance.
  • The company must complete the independent investigation and file the delayed quarterly report.
  • Nasdaq will review the plan and decide whether to grant an extension.

Key Dates

DateDescription
2024-11-13AMMO, Inc. filed a Form 12b-25 Notification of Late Filing with the SEC.
2024-11-20AMMO, Inc. received a deficiency notification letter from Nasdaq.
2024-11-26AMMO, Inc. issued a press release disclosing receipt of the deficiency notice.
2025-01-21Deadline for AMMO, Inc. to submit a plan to regain compliance with Nasdaq listing rules.
2025-05-19Potential deadline for AMMO, Inc. to regain compliance with Nasdaq listing rules if an extension is granted.

Keywords

Nasdaq, delisting, compliance, quarterly report, Form 10-Q, investigation, AMMO, Inc., listing rules, financial reporting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.